Cargando…
Norethindrone Acetate in the Medical Management of Adenomyosis
The role of norethindrone acetate (NA) in the management of adenomyosis was evaluated with a retrospective chart review of 28 premenopausal women between 27–49 years of age presenting with moderate to severe pelvic pain and bleeding. Bleeding and dysmenorrhea scores were analyzed using paired T-test...
Autores principales: | Muneyyirci-Delale, Ozgul, Chandrareddy, Ashadeep, Mankame, Siddhi, Osei-Tutu, Nanna, von Gizycki, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816659/ https://www.ncbi.nlm.nih.gov/pubmed/24281260 http://dx.doi.org/10.3390/ph5101120 |
Ejemplares similares
-
Medical management of recurrent endometrioma with long-term norethindrone acetate
por: Muneyyirci-Delale, Ozgul, et al.
Publicado: (2012) -
Management of dysfunctional uterine bleeding based on endometrial thickness
por: Muneyyirci-Delale, Ozgul, et al.
Publicado: (2010) -
Stress-Induced Hyperprolactinemia: Pathophysiology and Clinical Approach
por: Levine, Samara, et al.
Publicado: (2018) -
HT update: spotlight on estradiol/norethindrone acetate combination therapy
por: Casey, Colleen L, et al.
Publicado: (2008) -
Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis
por: Muneyyirci-Delale, Ozgul, et al.
Publicado: (2021)